Click to open contact form.
Your Global Partners in the Business of Innovation

Israeli Technology is Taking Regenerative Medicine into the Future

Publications / Oct 23, 2018

Congratulations to our client CollPlant and to United Therapeutics for announcing a Global Licensing and Commercialization Agreement for 3D bioprinting of Solid-Organ Scaffolds for Human Transplants.

Mark Cohen, Senior Partner and Chair of the Life Science Practice Group, represented Collplant in its intellectual property and due diligence matters for the Transaction.

See the full announcement HERE